GEFITINIB
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | GEFITINIB |
| DrugBank ID | DB00317 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 24 |
| DL Predictions (≥0.7) | 50 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| sweat gland cancer | TxGNN Knowledge Graph | L5 |
| basal cell carcinoma | TxGNN Knowledge Graph | L5 |
| sebaceous adenocarcinoma | TxGNN Knowledge Graph | L5 |
| skin carcinoma | TxGNN Knowledge Graph | L5 |
| pancreatic adenocarcinoma | TxGNN Knowledge Graph | L5 |
| prinzmetal angina | TxGNN Knowledge Graph | L5 |
| ventricular tachycardia | TxGNN Knowledge Graph | L5 |
| atrial fibrillation (disease) | TxGNN Knowledge Graph | L5 |
| hypertension | TxGNN Knowledge Graph | L5 |
| hypertensive disorder | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11